MedTrace Logo

LVAD Index and Clinical Outcomes in Continuous-Flow LVAD Patients

NCT07633535 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 34

Last updated 2026-06-08

No results posted yet for this study

Summary

This single-center, observational study evaluated the LVAD index, defined as device-estimated pump flow divided by body surface area, in adult patients supported with continuous-flow left ventricular assist devices. The study included 34 patients with end-stage heart failure who had either an HVAD or HeartMate 3 device and were followed for six months. The study assessed the relationship between LVAD index and selected routine biochemical markers related to hepatic and renal status, including ALT, AST, LDH, BUN, and creatinine. The study also evaluated whether LVAD index was associated with rehospitalization during follow-up.

Conditions

  • End-stage Heart Failure
  • Left Ventricular Assist Device
  • Mechanical Circulatory Support

Interventions

DEVICE

HeartWare Ventricular Assist Device

Patients in this group were supported with the HeartWare Ventricular Assist Device as part of routine clinical care. No device assignment or protocol-driven intervention was performed by the study investigators.

DEVICE

HeartMate 3 Left Ventricular Assist Device

Patients in this group were supported with the HeartMate 3 left ventricular assist device as part of routine clinical care. No device assignment or protocol-driven intervention was performed by the study investigators.

Sponsors & Collaborators

  • Antalya City Hospital

    collaborator OTHER

  • Akdeniz University Hospital

    collaborator OTHER

  • Gaziantep City Hospital

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-10-01
Primary Completion
2023-04-30
Completion
2023-04-30

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07633535 on ClinicalTrials.gov